• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Japan should retire OB too

Anonymous

Guest
LC's departure is a good start. It needs however to be augmented with the departure of OB who is by far the least effective VP of sales in our business. OB's reign of terror in this company needs to end. We need to bring back competency to Eisai. OB's lack of planning since 2007 has cost of us enough. It is time to clean house. OB needs to go.
 

<